Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.450
+0.030 (2.11%)
At close: Apr 28, 2026, 4:00 PM EDT
1.480
+0.030 (2.05%)
After-hours: Apr 28, 2026, 7:51 PM EDT
Telomir Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 50 | 46 | 123 | - | - | - |
| Market Cap Growth | -36.79% | -62.70% | - | - | - | - |
| Enterprise Value | 43 | 38 | 122 | - | - | - |
| Last Close Price | 1.45 | 1.33 | 4.12 | - | - | - |
| PB Ratio | 8.43 | 7.73 | 190.63 | - | - | - |
| P/TBV Ratio | 8.43 | 7.73 | 190.63 | - | - | - |
| Debt / Equity Ratio | 0.08 | 0.08 | 0.14 | 0.18 | -0.62 | -0.86 |
| Net Debt / Equity Ratio | -1.15 | -1.15 | -1.82 | 0.18 | -0.62 | -0.86 |
| Quick Ratio | 5.10 | 5.10 | 1.86 | 0.00 | 0.00 | - |
| Current Ratio | 5.14 | 5.14 | 1.94 | 0.33 | 0.05 | - |
| Return on Equity (ROE) | -317.65% | -317.65% | -810.18% | -1045.36% | - | - |
| Return on Assets (ROA) | -152.03% | -152.03% | -250.96% | -102.18% | - | - |
| Return on Capital Employed (ROCE) | -178.20% | -178.20% | -1903.80% | -114.70% | 91.10% | 100.00% |
| Earnings Yield | -20.89% | -22.77% | -13.49% | - | - | - |
| Buyback Yield / Dilution | -7.16% | -7.16% | -8.18% | -1.77% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.